{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T15:13:15Z","timestamp":1794669195142,"version":"4.9.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T00:00:00Z","timestamp":1568764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T00:00:00Z","timestamp":1568764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Inflammation is a natural defence response of the immune system against environmental insult, stress and injury, but hyper- and hypo-inflammatory responses can trigger diseases. Accumulating evidence suggests that inflammation is involved in multiple psychiatric disorders. Using inflammation-related factors as biomarkers of psychiatric disorders requires the proof of reproducibility and specificity of the changes in different disorders, which remains to be established. We performed a cross-disorder study by systematically evaluating the meta-analysis results of inflammation-related factors in eight major psychiatric disorders, including schizophrenia (SCZ), bipolar disorder (BD), autism spectrum disorder (ASD), major depression disorder (MDD), post-trauma stress disorder (PTSD), sleeping disorder (SD), obsessive\u2013compulsive disorder (OCD) and suicide. A total of 43 meta-analyses involving 704 publications on 44 inflammation-related factors were included in the study. We calculated the effect size and statistical power for every inflammation-related factor in each disorder. Our analyses showed that well-powered case\u2013control studies provided more consistent results than underpowered studies when one factor was meta-analysed by different researchers. After removing underpowered studies, 30 of the 44 inflammation-related factors showed significant alterations in at least one disorder based on well-powered meta-analyses. Eleven of them changed in patients of more than two disorders when compared with the controls. A few inflammation-related factors showed unique changes in specific disorders (e.g., IL-4 increased in BD, decreased in suicide, but had no change in MDD, ASD, PTSD and SCZ). MDD had the largest number of changes while SD has the least. Clustering analysis showed that closely related disorders share similar patterns of inflammatory changes, as genome-wide genetic studies have found. According to the effect size obtained from the meta-analyses, 13 inflammation-related factors would need &lt;50 cases and 50 controls to achieve 80% power to show significant differences (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.0016) between patients and controls. Changes in different states of MDD, SCZ or BD were also observed in various comparisons. Studies comparing first-episode SCZ to controls may have more reproducible findings than those comparing pre- and post-treatment results. Longitudinal, system-wide studies of inflammation regulation that can differentiate trait- and state-specific changes will be needed to establish valuable biomarkers.\n                  <\/jats:p>","DOI":"10.1038\/s41398-019-0570-y","type":"journal-article","created":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T05:05:26Z","timestamp":1568783126000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":430,"title":["Inflammation-related biomarkers in major psychiatric disorders: a cross-disorder assessment of reproducibility and specificity in 43 meta-analyses"],"prefix":"10.1038","volume":"9","author":[{"given":"Ning","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6432-9911","authenticated-orcid":false,"given":"Yan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiacheng","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5986-4415","authenticated-orcid":false,"given":"Chunyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,18]]},"reference":[{"key":"570_CR1","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/j.1744-6163.2009.00229.x","volume":"45","author":"JM Gill","year":"2009","unstructured":"Gill, J. M., Saligan, L., Woods, S. & Page, G. PTSD is associated with an excess of inflammatory immune activities. Perspect. Psychiatr. Care 45, 262\u2013277 (2009).","journal-title":"Perspect. Psychiatr. Care"},{"key":"570_CR2","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/npp.2016.146","volume":"42","author":"V Michopoulos","year":"2017","unstructured":"Michopoulos, V., Powers, A., Gillespie, C. F., Ressler, K. J. & Jovanovic, T. Inflammation in fear- and anxiety-based disorders: PTSD, GAD, and beyond. Neuropsychopharmacology 42, 254\u2013270 (2017).","journal-title":"Neuropsychopharmacology"},{"key":"570_CR3","first-page":"219","volume":"7","author":"Z Wang","year":"2016","unstructured":"Wang, Z. & Young, M. R. PTSD, a disorder with an immunological component. Front. Immunol. 7, 219 (2016).","journal-title":"Front. Immunol."},{"key":"570_CR4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/5584_2015_145","volume":"861","author":"I Tonhajzerova","year":"2015","unstructured":"Tonhajzerova, I. et al. Inflammatory activity in autism spectrum disorder. Adv. Exp. Med. Biol. 861, 93\u201398 (2015).","journal-title":"Adv. Exp. Med. Biol."},{"key":"570_CR5","first-page":"519","volume":"9","author":"JK Kern","year":"2015","unstructured":"Kern, J. K., Geier, D. A., Sykes, L. K. & Geier, M. R. Relevance of neuroinflammation and encephalitis in autism. Front. Cell. Neurosci. 9, 519 (2015).","journal-title":"Front. Cell. Neurosci."},{"key":"570_CR6","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1093\/schbul\/sby024","volume":"44","author":"N Muller","year":"2018","unstructured":"Muller, N. Inflammation in schizophrenia: pathogenetic aspects and therapeutic considerations. Schizophr. Bull. 44, 973\u2013982 (2018).","journal-title":"Schizophr. Bull."},{"key":"570_CR7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.4306\/pi.2016.13.1.18","volume":"13","author":"A Muneer","year":"2016","unstructured":"Muneer, A. Bipolar disorder: role of inflammation and the development of disease biomarkers. Psychiatry Investig. 13, 18\u201333 (2016).","journal-title":"Psychiatry Investig."},{"issue":"1","key":"570_CR8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/nyas.13712","volume":"1437","author":"Mois\u00e9s E. Bauer","year":"2018","unstructured":"Bauer M. E., Teixeira A. L. Inflammation in psychiatric disorders: what comes first? Ann. N. Y. Acad. Sci. 1437, 57\u201367 (2019).","journal-title":"Annals of the New York Academy of Sciences"},{"key":"570_CR9","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1001\/jama.2014.8276","volume":"312","author":"MJ Friedrich","year":"2014","unstructured":"Friedrich, M. J. Research on psychiatric disorders targets inflammation. J. Am. Med. Assoc. 312, 474\u2013476 (2014).","journal-title":"J. Am. Med. Assoc."},{"issue":"2","key":"570_CR10","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/mp.2016.167","volume":"23","author":"N Kappelmann","year":"2016","unstructured":"Kappelmann N., Lewis G., Dantzer R., Jones P. B., Khandaker G. M. Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions. Mol. Psychiatry 23, 335\u2013343 (2018).","journal-title":"Molecular Psychiatry"},{"key":"570_CR11","doi-asserted-by":"publisher","first-page":"732","DOI":"10.2174\/1570159X14666151208113700","volume":"14","author":"O Kohler","year":"2016","unstructured":"Kohler, O., Krogh, J., Mors, O. & Benros, M. E. Inflammation in depression and the potential for anti-inflammatory treatment. Curr. Neuropharmacol. 14, 732\u2013742 (2016).","journal-title":"Curr. Neuropharmacol."},{"key":"570_CR12","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1177\/0269881117711708","volume":"31","author":"P Kopschina Feltes","year":"2017","unstructured":"Kopschina Feltes, P. et al. Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune profile and non-responders to standard antidepressant therapy. J. Psychopharmacol. 31, 1149\u20131165 (2017).","journal-title":"J. Psychopharmacol."},{"key":"570_CR13","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","volume":"70","author":"BJ Miller","year":"2011","unstructured":"Miller, B. J., Buckley, P., Seabolt, W., Mellor, A. & Kirkpatrick, B. Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol. Psychiatry 70, 663\u2013671 (2011).","journal-title":"Biol. Psychiatry"},{"issue":"12","key":"570_CR14","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3390\/brainsci7110144","volume":"7","author":"Joshua Rosenblat","year":"2017","unstructured":"Rosenblat J. D., McIntyre R. S. Bipolar disorder and immune dysfunction: epidemiological findings, proposed pathophysiology and clinical implications. Brain Sci. 7, (2017).","journal-title":"Brain Sciences"},{"key":"570_CR15","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0924-977X(99)00062-0","volume":"10","author":"M Maes","year":"2000","unstructured":"Maes, M. et al. Effects of atypical antipsychotics on the inflammatory response system in schizophrenic patients resistant to treatment with typical neuroleptics. Eur. Neuropsychopharmacol. 10, 119\u2013124 (2000).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"570_CR16","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.2298\/VSP140526016S","volume":"72","author":"V Stefanovic","year":"2015","unstructured":"Stefanovic, V. et al. The effect of antipsychotic drugs on nonspecific inflammation markers in the first episode of schizophrenia. Vojnosanit. Pregl. 72, 1085\u20131092 (2015).","journal-title":"Vojnosanit. Pregl."},{"key":"570_CR17","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1159\/000356536","volume":"21","author":"Z Zajkowska","year":"2014","unstructured":"Zajkowska, Z. & Mondelli, V. First-episode psychosis: an inflammatory state? Neuroimmunomodulation 21, 102\u2013108 (2014).","journal-title":"Neuroimmunomodulation"},{"key":"570_CR18","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1038\/npp.2011.132","volume":"36","author":"J Hannestad","year":"2011","unstructured":"Hannestad, J., DellaGioia, N. & Bloch, M. The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology 36, 2452\u20132459 (2011).","journal-title":"Neuropsychopharmacology"},{"key":"570_CR19","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/0004867417701996","volume":"51","author":"AL Lopresti","year":"2017","unstructured":"Lopresti, A. L. Cognitive behaviour therapy and inflammation: a systematic review of its relationship and the potential implications for the treatment of depression. Aust. N.Z. J. Psychiatry 51, 565\u2013582 (2017).","journal-title":"Aust. N.Z. J. Psychiatry"},{"key":"570_CR20","unstructured":"WHO International Programme on Chemical Safety. Biomarkers in Risk Assessment: Validity and Validation. http:\/\/www.inchem.org\/documents\/ehc\/ehc\/ehc222.htm (2001)."},{"key":"570_CR21","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/COH.0b013e32833ed177","volume":"5","author":"K Strimbu","year":"2010","unstructured":"Strimbu, K. & Tavel, J. A. What are biomarkers? Curr. Opin. HIV AIDS 5, 463\u2013466 (2010).","journal-title":"Curr. Opin. HIV AIDS"},{"key":"570_CR22","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.4049\/jimmunol.1300825","volume":"192","author":"G Prencipe","year":"2014","unstructured":"Prencipe, G. et al. Nerve growth factor downregulates inflammatory response in human monocytes through TrkA. J. Immunol. 192, 3345\u20133354 (2014).","journal-title":"J. Immunol."},{"key":"570_CR23","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3389\/fncel.2017.00381","volume":"11","author":"J Li","year":"2017","unstructured":"Li, J. et al. Effect of VEGF on inflammatory regulation, neural survival, and functional improvement in rats following a complete spinal cord transection. Front. Cell. Neurosci. 11, 381 (2017).","journal-title":"Front. Cell. Neurosci."},{"key":"570_CR24","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/jcb.240400208","volume":"40","author":"SM Wahl","year":"1989","unstructured":"Wahl, S. M., Wong, H. & McCartney-Francis, N. Role of growth factors in inflammation and repair. J. Cell Biochem 40, 193\u2013199 (1989).","journal-title":"J. Cell Biochem"},{"key":"570_CR25","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","volume":"71","author":"MB Howren","year":"2009","unstructured":"Howren, M. B., Lamkin, D. M. & Suls, J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom. Med. 71, 171\u2013186 (2009).","journal-title":"Psychosom. Med."},{"key":"570_CR26","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.jad.2013.06.004","volume":"150","author":"V Valkanova","year":"2013","unstructured":"Valkanova, V., Ebmeier, K. P. & Allan, C. L. CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies. J. Affect. Disord. 150, 736\u2013744 (2013).","journal-title":"J. Affect. Disord."},{"key":"570_CR27","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.exger.2017.12.005","volume":"102","author":"KJ Smith","year":"2018","unstructured":"Smith, K. J., Au, B., Ollis, L. & Schmitz, N. The association between C-reactive protein, interleukin-6 and depression among older adults in the community: a systematic review and meta-analysis. Exp. Gerontol. 102, 109\u2013132 (2018).","journal-title":"Exp. Gerontol."},{"key":"570_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G. & Group, P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 6, e1000097 (2009).","journal-title":"PLoS Med."},{"key":"570_CR29","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.biopsych.2014.10.014","volume":"78","author":"C Black","year":"2015","unstructured":"Black, C. & Miller, B. J. Meta-analysis of cytokines and chemokines in suicidality: distinguishing suicidal versus nonsuicidal patients. Biol. Psychiatry 78, 28\u201337 (2015).","journal-title":"Biol. Psychiatry"},{"key":"570_CR30","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.bbi.2015.02.004","volume":"46","author":"D Ducasse","year":"2015","unstructured":"Ducasse, D., Olie, E., Guillaume, S., Artero, S. & Courtet, P. A meta-analysis of cytokines in suicidal behavior. Brain Behav. Immun. 46, 203\u2013211 (2015).","journal-title":"Brain Behav. Immun."},{"key":"570_CR31","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jpsychires.2016.11.012","volume":"86","author":"S Rao","year":"2017","unstructured":"Rao, S. et al. Peripheral blood nerve growth factor levels in major psychiatric disorders. J. Psychiatr. Res. 86, 39\u201345 (2017).","journal-title":"J. Psychiatr. Res."},{"key":"570_CR32","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.jpsychires.2013.05.018","volume":"47","author":"K Munkholm","year":"2013","unstructured":"Munkholm, K., Brauner, J. V., Kessing, L. V. & Vinberg, M. Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis. J. Psychiatr. Res. 47, 1119\u20131133 (2013).","journal-title":"J. Psychiatr. Res."},{"key":"570_CR33","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.biopsych.2013.01.007","volume":"74","author":"A Modabbernia","year":"2013","unstructured":"Modabbernia, A., Taslimi, S., Brietzke, E. & Ashrafi, M. Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies. Biol. Psychiatry 74, 15\u201325 (2013).","journal-title":"Biol. Psychiatry"},{"key":"570_CR34","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jad.2012.06.010","volume":"144","author":"K Munkholm","year":"2013","unstructured":"Munkholm, K., Vinberg, M. & Vedel Kessing, L. Cytokines in bipolar disorder: a systematic review and meta-analysis. J. Affect Disord. 144, 16\u201327 (2013).","journal-title":"J. Affect Disord."},{"key":"570_CR35","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","volume":"67","author":"Y Dowlati","year":"2010","unstructured":"Dowlati, Y. et al. A meta-analysis of cytokines in major depression. Biol. Psychiatry 67, 446\u2013457 (2010).","journal-title":"Biol. Psychiatry"},{"key":"570_CR36","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/acps.12698","volume":"135","author":"CA Kohler","year":"2017","unstructured":"Kohler, C. A. et al. Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies. Acta Psychiatr. Scand. 135, 373\u2013387 (2017).","journal-title":"Acta Psychiatr. Scand."},{"key":"570_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pnpbp.2016.02.006","volume":"68","author":"HA Eyre","year":"2016","unstructured":"Eyre, H. A. et al. A meta-analysis of chemokines in major depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 68, 1\u20138 (2016).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"570_CR38","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/mp.2017.205","volume":"23","author":"SP Leighton","year":"2018","unstructured":"Leighton, S. P. et al. Chemokines in depression in health and in inflammatory illness: a systematic review and meta-analysis. Mol. Psychiatry 23, 48\u201358 (2018).","journal-title":"Mol. Psychiatry"},{"key":"570_CR39","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3758\/BRM.41.4.1149","volume":"41","author":"F Faul","year":"2009","unstructured":"Faul, F., Erdfelder, E., Buchner, A. & Lang, A. G. Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav. Res Methods 41, 1149\u20131160 (2009).","journal-title":"Behav. Res Methods"},{"key":"570_CR40","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/ng.2711","volume":"45","author":"SH Lee","year":"2013","unstructured":"Cross-Disorder Group of the Psychiatric Genomics C, Lee, S. H. et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat. Genet. 45, 984\u2013994 (2013).","journal-title":"Nat. Genet."},{"key":"570_CR41","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.schres.2013.10.011","volume":"151","author":"V Tourjman","year":"2013","unstructured":"Tourjman, V. et al. Antipsychotics\u2019 effects on blood levels of cytokines in schizophrenia: a meta-analysis. Schizophr. Res. 151, 43\u201347 (2013).","journal-title":"Schizophr. Res."},{"key":"570_CR42","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.neubiorev.2017.03.003","volume":"77","author":"E Capuzzi","year":"2017","unstructured":"Capuzzi, E., Bartoli, F., Crocamo, C., Clerici, M. & Carra, G. Acute variations of cytokine levels after antipsychotic treatment in drug-naive subjects with a first-episode psychosis: a meta-analysis. Neurosci. Biobehav. Rev. 77, 122\u2013128 (2017).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"570_CR43","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S2215-0366(16)30370-4","volume":"3","author":"BS Fernandes","year":"2016","unstructured":"Fernandes, B. S. et al. C-reactive protein concentrations across the mood spectrum in bipolar disorder: a systematic review and meta-analysis. Lancet Psychiatry 3, 1147\u20131156 (2016).","journal-title":"Lancet Psychiatry"},{"key":"570_CR44","doi-asserted-by":"publisher","first-page":"142","DOI":"10.4088\/JCP.14r09007","volume":"76","author":"AA Dargel","year":"2015","unstructured":"Dargel, A. A., Godin, O., Kapczinski, F., Kupfer, D. J. & Leboyer, M. C-reactive protein alterations in bipolar disorder: a meta-analysis. J. Clin. Psychiatry 76, 142\u2013150 (2015).","journal-title":"J. Clin. Psychiatry"},{"key":"570_CR45","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1038\/mp.2016.3","volume":"21","author":"DR Goldsmith","year":"2016","unstructured":"Goldsmith, D. R., Rapaport, M. H. & Miller, B. J. A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol. Psychiatry 21, 1696\u20131709 (2016).","journal-title":"Mol. Psychiatry"},{"key":"570_CR46","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.schres.2014.03.005","volume":"155","author":"R Upthegrove","year":"2014","unstructured":"Upthegrove, R., Manzanares-Teson, N. & Barnes, N. M. Cytokine function in medication-naive first episode psychosis: a systematic review and meta-analysis. Schizophr. Res. 155, 101\u2013108 (2014).","journal-title":"Schizophr. Res."},{"key":"570_CR47","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S1359-6101(02)00026-6","volume":"13","author":"T Hanada","year":"2002","unstructured":"Hanada, T. & Yoshimura, A. Regulation of cytokine signaling and inflammation. Cytokine Growth Factor Rev. 13, 413\u2013421 (2002).","journal-title":"Cytokine Growth Factor Rev."},{"key":"570_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002480","volume":"8","author":"S Naitza","year":"2012","unstructured":"Naitza, S. et al. A genome-wide association scan on the levels of markers of inflammation in Sardinians reveals associations that underpin its complex regulation. PLoS Genet. 8, e1002480 (2012).","journal-title":"PLoS Genet."},{"key":"570_CR49","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.tem.2013.09.006","volume":"24","author":"A Toubal","year":"2013","unstructured":"Toubal, A., Treuter, E., Clement, K. & Venteclef, N. Genomic and epigenomic regulation of adipose tissue inflammation in obesity. Trends Endocrinol. Metab. 24, 625\u2013634 (2013).","journal-title":"Trends Endocrinol. Metab."},{"key":"570_CR50","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1038\/nature03985","volume":"437","author":"SE Calvano","year":"2005","unstructured":"Calvano, S. E. et al. A network-based analysis of systemic inflammation in humans. Nature 437, 1032\u20131037 (2005).","journal-title":"Nature"},{"key":"570_CR51","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.psyneuen.2016.10.010","volume":"75","author":"R Belzeaux","year":"2017","unstructured":"Belzeaux, R. et al. How to: measuring blood cytokines in biological psychiatry using commercially available multiplex immunoassays. Psychoneuroendocrinology 75, 72\u201382 (2017).","journal-title":"Psychoneuroendocrinology"},{"key":"570_CR52","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3390\/ijms17040472","volume":"17","author":"AM Manzardo","year":"2016","unstructured":"Manzardo, A. M., Poje, A. B., Penick, E. C. & Butler, M. G. Multiplex immunoassay of plasma cytokine levels in men with alcoholism and the relationship to psychiatric assessments. Int. J. Mol. Sci. 17, 472 (2016).","journal-title":"Int. J. Mol. Sci."},{"key":"570_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2017.31","volume":"7","author":"DD Kiraly","year":"2017","unstructured":"Kiraly, D. D. et al. Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome. Transl. Psychiatry 7, e1065 (2017).","journal-title":"Transl. Psychiatry"},{"key":"570_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s13229-017-0176-2","volume":"8","author":"A Masi","year":"2017","unstructured":"Masi, A. et al. Cytokine levels and associations with symptom severity in male and female children with autism spectrum disorder. Mol. Autism 8, 63 (2017).","journal-title":"Mol. Autism"},{"key":"570_CR55","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1503\/jpn.120065","volume":"37","author":"R Joober","year":"2012","unstructured":"Joober, R., Schmitz, N., Annable, L. & Boksa, P. Publication bias: what are the challenges and can they be overcome? J. Psychiatry Neurosci. 37, 149\u2013152 (2012).","journal-title":"J. Psychiatry Neurosci."},{"key":"570_CR56","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1136\/thx.2003.012468","volume":"59","author":"H van der Vaart","year":"2004","unstructured":"van der Vaart, H., Postma, D. S., Timens, W. & ten Hacken, N. H. Acute effects of cigarette smoke on inflammation and oxidative stress: a review. Thorax 59, 713\u2013721 (2004).","journal-title":"Thorax"},{"key":"570_CR57","doi-asserted-by":"publisher","first-page":"3758590","DOI":"10.1155\/2016\/3758590","volume":"2016","author":"SP Neupane","year":"2016","unstructured":"Neupane, S. P., Skulberg, A., Skulberg, K. R., Aass, H. C. & Bramness, J. G. Cytokine changes following acute ethanol intoxication in healthy men: a crossover study. Mediators Inflamm. 2016, 3758590 (2016).","journal-title":"Mediators Inflamm."},{"key":"570_CR58","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.resp.2013.01.013","volume":"187","author":"O Rom","year":"2013","unstructured":"Rom, O., Avezov, K., Aizenbud, D. & Reznick, A. Z. Cigarette smoking and inflammation revisited. Respir. Physiol. Neurobiol. 187, 5\u201310 (2013).","journal-title":"Respir. Physiol. Neurobiol."},{"key":"570_CR59","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/jnci\/dju294","volume":"106","author":"MS Shiels","year":"2014","unstructured":"Shiels, M. S. et al. Cigarette smoking and variations in systemic immune and inflammation markers. J. Natl Cancer Inst. 106, 11 (2014).","journal-title":"J. Natl Cancer Inst."},{"issue":"5","key":"570_CR60","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1111\/adb.12543","volume":"23","author":"Laura Orio","year":"2017","unstructured":"Orio L., et al. Young alcohol binge drinkers have elevated blood endotoxin, peripheral inflammation and low cortisol levels: neuropsychological correlations in women. Addict. Biol. 23, 1130\u20131144 (2018).","journal-title":"Addiction Biology"},{"key":"570_CR61","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1007\/s00213-016-4218-9","volume":"233","author":"MA Calcia","year":"2016","unstructured":"Calcia, M. A. et al. Stress and neuroinflammation: a systematic review of the effects of stress on microglia and the implications for mental illness. Psychopharmacology 233, 1637\u20131650 (2016).","journal-title":"Psychopharmacology"},{"key":"570_CR62","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1046\/j.1440-1711.2001.01028.x","volume":"79","author":"EF Morand","year":"2001","unstructured":"Morand, E. F. & Leech, M. Hypothalamic-pituitary-adrenal axis regulation of inflammation in rheumatoid arthritis. Immunol. Cell Biol. 79, 395\u2013399 (2001).","journal-title":"Immunol. Cell Biol."},{"key":"570_CR63","doi-asserted-by":"publisher","first-page":"16574","DOI":"10.1073\/pnas.1310655110","volume":"110","author":"ND Powell","year":"2013","unstructured":"Powell, N. D. et al. Social stress up-regulates inflammatory gene expression in the leukocyte transcriptome via beta-adrenergic induction of myelopoiesis. Proc. Natl Acad. Sci. USA 110, 16574\u201316579 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"570_CR64","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1196\/annals.1333.052","volume":"1043","author":"J Uribarri","year":"2005","unstructured":"Uribarri, J. et al. Diet-derived advanced glycation end products are major contributors to the body\u2019s AGE pool and induce inflammation in healthy subjects. Ann. N. Y. Acad. Sci. 1043, 461\u2013466 (2005).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"570_CR65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0071414","volume":"8","author":"X Xu","year":"2013","unstructured":"Xu, X. et al. Inflammatory response to fine particulate air pollution exposure: neutrophil versus monocyte. PloS ONE 8, e71414 (2013).","journal-title":"PloS ONE"},{"key":"570_CR66","unstructured":"Lopez-Candales A., Hernandez Burgos P. M., Hernandez-Suarez D. F., Harris D. Linking chronic inflammation with cardiovascular disease: from normal aging to the metabolic syndrome. J. Nat. Sci. 3, (2017)."},{"key":"570_CR67","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","volume":"140","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov, S. I., Greten, F. R. & Karin, M. Immunity, inflammation, and cancer. Cell 140, 883\u2013899 (2010).","journal-title":"Cell"},{"key":"570_CR68","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s11845-016-1464-0","volume":"186","author":"A Korniluk","year":"2017","unstructured":"Korniluk, A., Koper, O., Kemona, H. & Dymicka-Piekarska, V. From inflammation to cancer. Ir. J. Med. Sci. 186, 57\u201362 (2017).","journal-title":"Ir. J. Med. Sci."},{"key":"570_CR69","doi-asserted-by":"publisher","first-page":"431","DOI":"10.2174\/157340006778699729","volume":"2","author":"Y Chen","year":"2006","unstructured":"Chen, Y., Bidwell, L. C. & Norton, D. Trait vs. state markers for schizophrenia: identification and characterization through visual processes. Curr. Psychiatry Rev. 2, 431\u2013438 (2006).","journal-title":"Curr. Psychiatry Rev."},{"key":"570_CR70","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1002\/JLB.1RU1117-428R","volume":"103","author":"SA Sonar","year":"2018","unstructured":"Sonar, S. A. & Lal, G. Blood-brain barrier and its function during inflammation and autoimmunity. J. Leukoc. Biol. 103, 839\u2013853 (2018).","journal-title":"J. Leukoc. Biol."},{"key":"570_CR71","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/j.1939-1676.2000.tb02248.x","volume":"14","author":"AA Webb","year":"2000","unstructured":"Webb, A. A. & Muir, G. D. The blood-brain barrier and its role in inflammation. J. Vet. Intern. Med 14, 399\u2013411 (2000).","journal-title":"J. Vet. Intern. Med"},{"key":"570_CR72","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1038\/nn.4156","volume":"18","author":"EC Psych","year":"2015","unstructured":"Psych, E. C. et al. The PsychENCODE project. Nat. Neurosci. 18, 1707\u20131712 (2015).","journal-title":"Nat. Neurosci."},{"key":"570_CR73","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2174\/1570159X14666151204122017","volume":"14","author":"MN Catorce","year":"2016","unstructured":"Catorce, M. N. & Gevorkian, G. LPS-induced murine neuroinflammation model: main features and suitability for pre-clinical assessment of nutraceuticals. Curr. Neuropharmacol. 14, 155\u2013164 (2016).","journal-title":"Curr. Neuropharmacol."},{"key":"570_CR74","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jneumeth.2016.06.018","volume":"272","author":"CC Chiu","year":"2016","unstructured":"Chiu, C. C. et al. Neuroinflammation in animal models of traumatic brain injury. J. Neurosci. Methods 272, 38\u201349 (2016).","journal-title":"J. Neurosci. Methods"},{"issue":"9","key":"570_CR75","doi-asserted-by":"publisher","first-page":"pyw028","DOI":"10.1093\/ijnp\/pyw028","volume":"19","author":"Jennifer L. Remus","year":"2016","unstructured":"Remus J. L., Dantzer R. Inflammation models of depression in rodents: relevance to psychotropic drug discovery. Int. J. Neuropsychopharmacol. 19, (2016).","journal-title":"International Journal of Neuropsychopharmacology"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-019-0570-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-019-0570-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-019-0570-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T10:46:24Z","timestamp":1671187584000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-019-0570-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,18]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["570"],"URL":"https:\/\/doi.org\/10.1038\/s41398-019-0570-y","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,18]]},"assertion":[{"value":"9 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"233"}}